GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series
GRI Bio (NASDAQ: GRI), a biotechnology company focused on developing Natural Killer T (NKT) cell...
Closing
GRI Bio (NASDAQ: GRI), a biotechnology company focused on developing Natural Killer T (NKT) cell...
